Featured news
Bloggers have much to say about the week's big story, the new, and apparently exceptionally unpopular, recommendations on breast cancer and mammograms.
A black hole is the perfect place for stuff you never want to see again. So Wired Science is joining Wired.com's extended black hole party by chucking in some of the worst, most overused science cliches.
No better place to commence this new column on science writing for science writers than with some optimism about clearing up our profession's cloudy future. Literally cloudy, according to Dot Earth's Andrew Revkin, who discusses what he calls "cloud financing" of investigative work by science journalists. Revkin's example is a Nov. 9 New York Times piece by Lindsey Hoshaw on vast trash heaps in the ocean.
On his first day in office in January, President Barack Obama went to work for science writers as he issued a directive on transparency and access to government information. The new president issued an Executive Memo on "Openness and Transparency," reversing a Bush-era rule that favored secrecy over disclosure for requests filed under the Freedom of Information Act (FOIA).
In keeping with our commitment to transparency and free exchange of information, NASW has joined with the Association of Health Care Journalists (AHCJ), the Society of Professional Journalists (SPJ) and others in urging the U.S. Food and Drug Administration to rescind a policy that currently requires notification and official approval before FDA officials are allowed to speak with journalists.
Kevin Gurney, an associate professor at Purdue University, showed high-resolution animated graphics of the past, present and future of climate change at CASW's 2009 New Horizons in Science briefing at the University of Texas at Austin. Unfortunately, his pictures suggest that carbon emissions may soon look a lot worse.
Self-described as a science writer and the Bush Administration's worst nightmare, physician Bruce M. Psaty told CASW conference attendees what it is like to blow the whistle on the Federal Drug Administration's drug approval process.
Imagine a team of researchers in the U.S. able to remotely track a deployed soldier's reactions to combat stress in Iraq with the accuracy to determine susceptibility to post-traumatic stress disorder (PTSD) and the ability to administer quick preventative treatments. That is just one of the potential implications of Michael Telch and his team's research at the University of Texas at Austin in collaboration with 184 volunteer soldiers from Fort Hood.